DarioHealth (NSDQ:DRIO) said today that authorities in Australia approved the version of its blood glucose monitoring system that fits with the Lightning connector on Apple’s iPhone 7, 8 and X smartphones.
Users in Australia will be able to buy the Lightning-enabled Dario device by Jan. 2018, the Israel-based company reported.
“We are thrilled to announce that DarioHealth secured TGA approval to offer the Lightning-enabled version and can now accommodate users in Australia who have updated their Apple devices,” chairman & CEO Erez Raphael said in prepared remarks. “We hope to help the 1.7 million Australians who have diabetes, specifically the more than 100,000 Australians who have been diagnosed with diabetes in the past year.”
The company said it expects to win approval for its technology in the U.S. and Canada in the coming months.
DRIO shares were trading at $1.60 apiece in mid-morning activity today, up 6.9%.
DarioHealth’s platform includes a blood glucose monitoring system, which connects via a headphone jack to a mobile device, a lancing device and test strips, which help diabetes patients monitor their blood glucose throughout the day. There is no carrying case or batteries, according to DarioHealth, and users can access real-time and historical blood glucose data to watch out for trends.
Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.